Oklahoma House Bill HB1915

Oklahoma 2026 Regular Session

• Introduced: 2/3/25
• Refer: 2/4/25

Caption

Artificial intelligence; AI devices in health care; qualified end-user; deployer; quality assurance program; State Department of Health; effective date.

Impact

The legislation will have significant implications for state health laws, specifically concerning the deployment of AI in clinical settings. It necessitates the establishment of Quality Assurance Programs by deployers—hospitals, physician practices, and other health care facilities—to maintain oversight of AI devices. These programs will ensure compliance with federal standards set forth by regulatory bodies like the Food and Drug Administration (FDA), thereby enhancing the safety and efficacy of AI applications in patient care.

Summary

House Bill 1915 introduces a comprehensive regulatory framework for the deployment and utilization of artificial intelligence (AI) devices in health care settings. The bill mandates that AI devices, defined under federal law, be exclusively used by qualified end-users—licensed physicians trained to assess and oversee the outputs of these devices. This stipulation aims to ensure high standards of patient care by requiring that medical decisions involving AI outputs be made only by trained professionals.

Contention

Notable points of contention surrounding HB 1915 include the balance between technological innovation and patient safety. While advocates argue that the bill fosters responsible implementation of AI in health care, some critics express concerns over the potential for over-reliance on automated outputs without sufficient human oversight. The requirement for regular performance evaluations and documented corrections aims to mitigate risks, yet some stakeholders question whether these measures are adequate to manage the complexities associated with AI deployment in sensitive health contexts.